Streetbeat News

ZIVO

Zivo Bioscience Inc

https://zivobioscience.com/

CEO

Andrew Dahl

Employees

Industry

Biological Product (except Diagnostic) Manufacturing

zivo bioscience, inc., a u.s.-based r&d firm, is dedicated to the study, development and commercialization of natural nutritional compounds and bioactive molecules derived from proprietary algal strains.

Open

20.90

Mkt cap

74M

Volume

723

High

21.00

P/E Ratio

-4.35

52-wk high

22.15

Low

20.90

Div yield

N/A

52-wk low

0.48

Zivo Bioscience has filed a prospectus for 2,996,260 shares of common stock underlying Series A and Series B common warrants by a selling stockholder. The filing was made with the SEC.

Portfolio Pulse from Charles Gross

July 28, 2023 | 10:08 am

ZIVO Bioscience, Inc. has started selling its proprietary algal biomass as human food. This move marks the company's entry into the human food market.

Portfolio Pulse from Bill Haddad

July 26, 2023 | 8:44 pm

The article lists five oversold stocks in the consumer staples sector that could be potential investment opportunities. These include The Estée Lauder Companies Inc. (EL), Smart for Life, Inc. (SMFL), ZIVO Bioscience, Inc. (ZIVO), BRC Inc. (BRCC), and AppHarvest, Inc. (APPH). The stocks are considered oversold as their Relative Strength Index (RSI) is near or below 30. The companies have experienced various events such as price target downgrades, compliance with Nasdaq listing requirements, direct offerings, better-than-expected sales, and Chapter 11 filings.

Portfolio Pulse from Lisa Levin

July 25, 2023 | 11:29 am

On Monday, 70 companies hit new 52-week lows. Estee Lauder Cos was the largest firm by market cap to set a new 52-week low, while 9 Meters Biopharma was the smallest. AppHarvest was the biggest loser, trading down 70.3% to reach its 52-week low, while SWK Holdings was the biggest winner, with shares trading up 0.0% after rebounding from its new 52-week low.

Portfolio Pulse from Benzinga Insights

July 24, 2023 | 7:48 pm

On Monday, 50 companies reached new 52-week lows. The biggest company by market cap to set a new 52-week low was Verizon Communications (NYSE:VZ), while the smallest was Galmed Pharmaceuticals (NASDAQ:GLMD). Novan (NASDAQ:NOVN) was the biggest loser of the morning session, dropping 72.16% to reach its new 52-week low. Cal-Maine Foods (NASDAQ:CALM) shares were the most resilient, rising 0.06% from its new 52-week low.

Portfolio Pulse from Benzinga Insights

July 17, 2023 | 4:17 pm

ZIVO Bioscience has announced the pricing of a $4 million registered direct offering. The company plans to use the proceeds for general corporate purposes.

Portfolio Pulse from Benzinga Newsdesk

June 30, 2023 | 5:59 pm

Several stocks experienced significant movement in Thursday's mid-day session. Sigilon Therapeutics (SGTX) shares climbed 523.8% after Eli Lilly agreed to acquire the company. Eco Wave Power Global (WAVE) gained 47.4% after announcing plans for a share repurchase program. Franklin Covey Co. (FC) gained 25.2% following upbeat Q3 results. Carriage Services (CSV) surged 24.4% after its Board initiated a process to explore potential strategic alternatives. The Greenbrier Companies (GBX) gained 23.2% after reporting better-than-expected Q3 results and raising FY23 revenue guidance. On the downside, BioXcel Therapeutics (BTAI) shares dipped 62.2% after releasing topline results from a Phase 3 trial.

Portfolio Pulse from Lisa Levin

June 29, 2023 | 5:52 pm

Several stocks experienced significant pre-market movements. Notable gainers include Eco Wave Power Global AB (WAVE), Kintara Therapeutics (KTRA), and BlackBerry Limited (BB), while CorMedix Inc. (CRMD), iMedia Brands (IMBI), and Novan Inc. (NOVN) were among the losers. Factors influencing these movements include recent earnings reports, grant awards, and public offerings.

Portfolio Pulse from Lisa Levin

June 29, 2023 | 12:18 pm

Zivo Bioscience (NASDAQ:ZIVO) has received an updated dossier reaffirming its GRAS (Generally Recognized As Safe) designation for its proprietary algal biomass product as a human food ingredient. The GRAS status allows manufacturers and marketers to safely integrate ZIVO's algal biomass into food processing lines and products.

Portfolio Pulse from Happy Mohamed

May 30, 2023 | 12:47 pm

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.